Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,984.00
Bid: 1,980.00
Ask: 1,986.00
Change: 18.00 (0.92%)
Spread: 6.00 (0.303%)
Open: 1,966.00
High: 1,994.00
Low: 1,966.00
Prev. Close: 1,966.00
RCP Live PriceLast checked at -
RIT Capital Partners is an Investment Trust

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

17 Nov 2023 07:00

RNS Number : 7559T
RIT Capital Partners PLC
17 November 2023
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

 

17 November 2023

 

31 October 2023 Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 October 2023 (with debt at fair value) was 2,362p per £1 ordinary share (30 September 2023: 2,409p). This is after deduction of the second interim dividend of 19p per £1 ordinary share paid on 27 October 2023.

 

 

October 2023 Highlights

 

Global equities retreated in October as higher bond yields and renewed geopolitical concerns put pressure on equity valuations. In the US, buoyant economic data reinforced a higher-for-longer rate environment which pushed the 10-year Treasury yield above 5% for the first time since 2007. The S&P 500 declined by -2.1% over the month, while weakening economic growth in the UK and Europe led to declines of -3.7% for the FTSE 100 and -3.6% for the STOXX 600. Investor sentiment towards China weakened, with the CSI 300 down -3.1%. Gold rallied by ~7.3% as investors sought safe haven assets, while the US dollar strengthened slightly in the month.

 

Our portfolio declined less than the markets driven by our moderate net equity exposure, positive contributions from our Uncorrelated Strategies as well as our meaningful US dollar position.

 

·

Our Quoted Equities book detracted during the month. Positive contributions from Japanese holdings were offset by weakness in certain value positions, alongside declines in our healthcare and Chinese holdings.

·

Private Investments were approximately flat for the month, with no major movements from the new marks received from our private funds for Q3. As of 31 October, 12% of private funds were valued at 30 September reported valuations and 83% were held at 30 June valuations, with the remainder held at 31 March. All private direct positions are valued at 30 June.

·

Our Uncorrelated Strategies book was steady in October. Our macro strategies and gold position contributed positively during the month, while credit strategies detracted.

·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. In the month of October, the Company repurchased approximately 0.7 million shares on behalf of shareholders.

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVVQLFFXFLEFBL
Date   Source Headline
1st May 202412:00 pmRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSNet Asset Value(s)
4th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20242:27 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20245:22 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSNet Asset Value(s)
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20244:56 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSFinal Results
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 202410:32 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20245:13 pmRNSDirectorate Change
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20241:31 pmRNSCompany Announcement
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSNet Asset Value(s)
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSNet Asset Value(s)
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.